• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

P2X7受体的激活会诱导人源和鼠源B细胞表面的CD23迅速脱落。

Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.

作者信息

Pupovac Aleta, Geraghty Nicholas J, Watson Debbie, Sluyter Ronald

机构信息

1] School of Biological Sciences, University of Wollongong, Wollongong, New South Wales, Australia [2] Illawarra Health and Medical Research Institute, Wollongong, New South Wales, Australia.

出版信息

Immunol Cell Biol. 2015 Jan;93(1):77-85. doi: 10.1038/icb.2014.69. Epub 2014 Aug 26.

DOI:10.1038/icb.2014.69
PMID:25155463
Abstract

Activation of the P2X7 receptor by the extracellular damage-associated molecular pattern, adenosine 5'-triphosphate (ATP), induces the shedding of cell surface molecules including the low-affinity IgE receptor, CD23, from human leukocytes. A disintegrin and metalloprotease (ADAM) 10 mediates P2X7-induced shedding of CD23 from multiple myeloma RPMI 8226 B cells; however, whether this process occurs in primary B cells is unknown. The aim of the current study was to determine whether P2X7 activation induces the rapid shedding of CD23 from primary human and murine B cells. Flow cytometric and ELISA measurements showed that ATP treatment of human and murine B cells induced the rapid shedding of CD23. Treatment of cells with the specific P2X7 antagonist, AZ10606120, near-completely impaired ATP-induced CD23 shedding from both human and murine B cells. ATP-induced CD23 shedding was also impaired in B cells from P2X7 knockout mice. The absence of full-length, functional P2X7 in the P2X7 knockout mice was confirmed by immunoblotting of splenic cells, and by flow cytometric measurements of ATP-induced YO-PRO-1(2+) uptake into splenic B and T cells. The broad-spectrum metalloprotease antagonist, BB-94, and the ADAM10 antagonist, GI254023X, impaired P2X7-induced CD23 shedding from both human and murine B cells. These data indicate that P2X7 activation induces the rapid shedding of CD23 from primary human and murine B cells and that this process may be mediated by ADAM10.

摘要

细胞外损伤相关分子模式三磷酸腺苷(ATP)激活P2X7受体,可诱导包括低亲和力IgE受体CD23在内的细胞表面分子从人白细胞上脱落。整合素和金属蛋白酶(ADAM)10介导P2X7诱导的多发性骨髓瘤RPMI 8226 B细胞表面CD23的脱落;然而,这一过程是否发生在原代B细胞中尚不清楚。本研究的目的是确定P2X7激活是否会诱导原代人B细胞和鼠B细胞表面CD23的快速脱落。流式细胞术和酶联免疫吸附测定结果显示,ATP处理人B细胞和鼠B细胞可诱导CD23快速脱落。用特异性P2X7拮抗剂AZ10606120处理细胞,几乎完全抑制了ATP诱导的人B细胞和鼠B细胞表面CD23的脱落。P2X7基因敲除小鼠的B细胞中,ATP诱导的CD23脱落也受到抑制。通过对脾细胞进行免疫印迹以及对ATP诱导的脾B细胞和T细胞摄取YO-PRO-1(2+)进行流式细胞术检测,证实P2X7基因敲除小鼠中不存在全长功能性P2X7。广谱金属蛋白酶拮抗剂BB-94和ADAM10拮抗剂GI254023X均抑制了P2X7诱导的人B细胞和鼠B细胞表面CD23的脱落。这些数据表明,P2X7激活可诱导原代人B细胞和鼠B细胞表面CD23快速脱落,且这一过程可能由ADAM10介导。

相似文献

1
Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells.P2X7受体的激活会诱导人源和鼠源B细胞表面的CD23迅速脱落。
Immunol Cell Biol. 2015 Jan;93(1):77-85. doi: 10.1038/icb.2014.69. Epub 2014 Aug 26.
2
Human P2X7 receptor activation induces the rapid shedding of CXCL16.人类 P2X7 受体的激活诱导 CXCL16 的快速脱落。
Biochem Biophys Res Commun. 2013 Mar 22;432(4):626-31. doi: 10.1016/j.bbrc.2013.01.134. Epub 2013 Feb 18.
3
Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases.三磷酸腺苷诱导淋巴细胞表面CD23和L-选择素(CD62L)脱落是由同一受体但不同的金属蛋白酶介导的。
Blood. 1998 Aug 1;92(3):946-51.
4
The low affinity IgE receptor (CD23) is cleaved by the metalloproteinase ADAM10.低亲和力IgE受体(CD23)被金属蛋白酶ADAM10裂解。
J Biol Chem. 2007 May 18;282(20):14836-44. doi: 10.1074/jbc.M608414200. Epub 2007 Mar 27.
5
Adrenergic regulation of IgE involves modulation of CD23 and ADAM10 expression on exosomes.儿茶酚胺对 IgE 的调节涉及到细胞表面 CD23 和 ADAM10 表达的调节。
J Immunol. 2013 Dec 1;191(11):5383-97. doi: 10.4049/jimmunol.1301019. Epub 2013 Oct 18.
6
P2X7 receptor activation induces cell death and CD23 shedding in human RPMI 8226 multiple myeloma cells.P2X7受体激活可诱导人RPMI 8226多发性骨髓瘤细胞发生细胞死亡和CD23脱落。
Biochim Biophys Acta. 2010 Nov;1800(11):1173-82. doi: 10.1016/j.bbagen.2010.07.001. Epub 2010 Jul 18.
7
CD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.CD23 脱落酶 A 型整合素金属蛋白酶 10(ADAM10)对于 CD23 分选到 B 细胞来源的外泌体中也是必需的。
J Biol Chem. 2010 Nov 26;285(48):37531-41. doi: 10.1074/jbc.M110.141556. Epub 2010 Sep 28.
8
Soluble CD23 controls IgE synthesis and homeostasis in human B cells.可溶性 CD23 控制人类 B 细胞中的 IgE 合成和动态平衡。
J Immunol. 2012 Apr 1;188(7):3199-207. doi: 10.4049/jimmunol.1102689. Epub 2012 Mar 5.
9
Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors.细胞外5'-三磷酸腺苷通过激活P2X7受体诱导人树突状细胞表面CD23丢失。
Int Immunol. 2002 Dec;14(12):1415-21. doi: 10.1093/intimm/dxf111.
10
The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein.嘌呤能受体 P2X7 触发淀粉样前体蛋白的 α-分泌酶依赖性加工。
J Biol Chem. 2011 Jan 28;286(4):2596-606. doi: 10.1074/jbc.M110.200618. Epub 2010 Nov 16.

引用本文的文献

1
SARS-CoV-2 Spike Protein and Long COVID-Part 2: Understanding the Impact of Spike Protein and Cellular Receptor Interactions on the Pathophysiology of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与新冠后综合征——第2部分:了解刺突蛋白与细胞受体相互作用对新冠后综合征病理生理学的影响
Viruses. 2025 Apr 25;17(5):619. doi: 10.3390/v17050619.
2
Unraveling the SARS-CoV-2 spike protein long-term effect on neuro-PASC.揭示严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白对新冠后综合征(PASC)神经系统长期影响的奥秘。
Front Cell Neurosci. 2024 Dec 18;18:1481963. doi: 10.3389/fncel.2024.1481963. eCollection 2024.
3
A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice.

本文引用的文献

1
The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease.P2X7 受体通道:最新进展及 P2X7 拮抗剂在疾病模型中的应用。
Pharmacol Rev. 2014 Jul;66(3):638-75. doi: 10.1124/pr.113.008003.
2
R270C polymorphism leads to loss of function of the canine P2X7 receptor.R270C多态性导致犬P2X7受体功能丧失。
Physiol Genomics. 2014 Jul 15;46(14):512-22. doi: 10.1152/physiolgenomics.00195.2013. Epub 2014 May 13.
3
The P2X7 receptor-inflammasome complex has a role in modulating the inflammatory response in primary Sjögren's syndrome.
一种物种特异性抗人P2X7单克隆抗体可减轻人源化小鼠的移植物抗宿主病。
Pharmaceutics. 2023 Aug 31;15(9):2263. doi: 10.3390/pharmaceutics15092263.
4
The P2X7 Receptor in Autoimmunity.自身免疫中的P2X7受体
Int J Mol Sci. 2023 Sep 14;24(18):14116. doi: 10.3390/ijms241814116.
5
The P2X7 receptor in mucosal adaptive immunity.黏膜适应性免疫中的 P2X7 受体。
Purinergic Signal. 2024 Feb;20(1):9-19. doi: 10.1007/s11302-023-09939-w. Epub 2023 Apr 17.
6
Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.头颈部癌来源外泌体在 ATP 存在下对 B 细胞的差异免疫调节作用。
Int J Mol Sci. 2022 Nov 21;23(22):14446. doi: 10.3390/ijms232214446.
7
Physiologic roles of P2 receptors in leukocytes.P2 受体在白细胞中的生理作用。
J Leukoc Biol. 2022 Nov;112(5):983-1012. doi: 10.1002/JLB.2RU0421-226RR. Epub 2022 Jul 15.
8
P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.P2X7 受体的激活介导了来自鼠 NSC-34 运动神经元的超氧化物歧化酶 1(SOD1)的释放。
Purinergic Signal. 2022 Dec;18(4):451-467. doi: 10.1007/s11302-022-09863-5. Epub 2022 Apr 28.
9
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.基于嘌呤能信号转导的新型 COVID-19 过度炎症反应定义和治疗方法。
Purinergic Signal. 2022 Mar;18(1):13-59. doi: 10.1007/s11302-021-09814-6. Epub 2021 Nov 10.
10
Pathophysiological role of calcium channels and transporters in the multiple myeloma.钙通道和转运体在多发性骨髓瘤中的病理生理作用。
Cell Commun Signal. 2021 Sep 27;19(1):99. doi: 10.1186/s12964-021-00781-4.
P2X7 受体-炎性小体复合物在原发性干燥综合征的炎症反应调节中起作用。
J Intern Med. 2013 Nov;274(5):480-9. doi: 10.1111/joim.12115. Epub 2013 Aug 17.
4
Epistasis with HLA DR3 implicates the P2X7 receptor in the pathogenesis of primary Sjögren's syndrome.与HLA DR3的上位效应表明P2X7受体在原发性干燥综合征的发病机制中起作用。
Arthritis Res Ther. 2013 Jun 2;15(4):R71. doi: 10.1186/ar4248.
5
CAY10593 inhibits the human P2X7 receptor independently of phospholipase D1 stimulation.CAY10593 可独立于磷脂酶 D1 刺激抑制人 P2X7 受体。
Purinergic Signal. 2013 Dec;9(4):609-19. doi: 10.1007/s11302-013-9371-6. Epub 2013 Jun 21.
6
P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia.P2X7 受体激活诱导小鼠 EOC13 小胶质细胞中活性氧的形成和细胞死亡。
Mediators Inflamm. 2013;2013:271813. doi: 10.1155/2013/271813. Epub 2013 Jan 27.
7
Human P2X7 receptor activation induces the rapid shedding of CXCL16.人类 P2X7 受体的激活诱导 CXCL16 的快速脱落。
Biochem Biophys Res Commun. 2013 Mar 22;432(4):626-31. doi: 10.1016/j.bbrc.2013.01.134. Epub 2013 Feb 18.
8
Association between P2X7 Receptor Polymorphisms and Bone Status in Mice.小鼠P2X7受体多态性与骨状态之间的关联
J Osteoporos. 2012;2012:637986. doi: 10.1155/2012/637986. Epub 2012 Aug 5.
9
P2X7 receptor activation induces inflammatory responses in salivary gland epithelium.P2X7 受体的激活可诱导唾液腺上皮的炎症反应。
Am J Physiol Cell Physiol. 2012 Oct 1;303(7):C790-801. doi: 10.1152/ajpcell.00072.2012. Epub 2012 Aug 8.
10
Alternative splicing of the N-terminal cytosolic and transmembrane domains of P2X7 controls gating of the ion channel by ADP-ribosylation.N 端胞质和跨膜结构域的 P2X7 的可变剪接通过 ADP-核糖基化控制离子通道的门控。
PLoS One. 2012;7(7):e41269. doi: 10.1371/journal.pone.0041269. Epub 2012 Jul 27.